ATYR

aTyr Pharma (ATYR)

About aTyr Pharma (ATYR)

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Details

Daily high

$0.94

Daily low

$0.90

Price at open

$0.92

52 Week High

$7.29

52 Week Low

$0.64

Market cap

91.8M

Dividend yield

0.00%

Volume

15,036

Avg. volume

1.6M

P/E ratio

-1.18

aTyr Pharma News